Obstructive sleep apnea hypopnea syndrome and metabolic syndrome: a synergistic cardiovascular risk factor (Q38063307)

28 August 2017

1 reference

title

Obstructive sleep apnea hypopnea syndrome and metabolic syndrome: a synergistic cardiovascular risk factor (English)

1 reference

28 August 2017

0 references

1 reference

obstructive sleep apnea

1 reference

Becky Lynn Goodson

1

1 reference

PubMed ID

23190127

28 August 2017

Shu-Fen Wung

series ordinal

2

1 reference

PubMed ID

23190127

28 August 2017

Kristen Hedger Archbold

series ordinal

3

1 reference

28 August 2017

14 August 2012

1 reference

Journal of the American Academy of Nurse Practitioners

28 August 2017

1 reference

28 August 2017

24

1 reference

28 August 2017

12

1 reference

28 August 2017

695-703

1 reference

Treatment options for obstructive sleep apnea.

28 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Adherence to positive airway pressure therapy in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Hypertension and obstructive sleep apnoea syndrome: current perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Systemic and airway inflammation in sleep apnea and obesity: the role of ICAM-1 and IL-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-34).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Obstructive sleep apnea is highly prevalent and correlates with impaired glycemic control in consecutive patients with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Likelihood ratios for a sleep apnea clinical prediction rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Obstructive sleep apnea syndrome and hypertension: mechanism of the linkage and 24-h blood pressure control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Association of coronary artery calcification with obstructive sleep apnea and obesity in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Executive Summary: Heart Disease and Stroke Statistics—2010 Update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

A Relationship between the Obstructive Sleep Apnea Syndrome and the Erythrocyte Sedimentation Rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Association between lipid peroxidation and inflammation in obstructive sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Silent brain infarction and platelet activation in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Oxidative stress and metabolic changes after continuous positive airway pressure treatment according to previous metabolic disorders in sleep apnea-hypopnea syndrome patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Empirical evidence for "syndrome Z": a hierarchical 5-factor model of the metabolic syndrome incorporating sleep disturbance measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Physical examination: Mallampati score as an independent predictor of obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

CPAP treatment in the coexistence of obstructive sleep apnea syndrome and metabolic syndrome, results of one year follow up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Obstructive sleep apnea (OSA) in primary care: evidence-based practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Sleep apnea: epidemiology, pathophysiology, and relation to cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

The association of OSA with insulin resistance, inflammation and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Carotid artery wall thickness in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Predictors of compliance with continuous positive airway pressure treatment in patients with obstructive sleep apnea and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Obstructive Sleep Apnea in Family Members

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea-hypopnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

Elevated plasminogen activator inhibitor 1 in sleep apnea and its relation to the metabolic syndrome: an investigation in 2 different study samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1745-7599.2012.00771.X

10.1111/J.1745-7599.2012.00771.X

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23190127